Neoadjuvant Therapy in Early Breast Cancer: Treatment Considerations and Common Debates in Practice
H Cain1, I R Macpherson2, M Beresford3
1Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|July 4, 2017
Summary
Neoadjuvant therapy provides benefits for early breast cancer patients. This review assists multidisciplinary teams in selecting suitable candidates for neoadjuvant treatment, optimizing care.
Area of Science:
- Oncology
- Breast Cancer Research
Background:
- Neoadjuvant therapy is a crucial treatment option for early breast cancer.
- Despite demonstrated efficacy, neoadjuvant treatment utilization is inconsistent across clinical settings.
Purpose of the Study:
- To review the clinical evidence supporting neoadjuvant therapy in early-stage breast cancer.
- To guide multidisciplinary teams in patient selection and treatment planning for neoadjuvant therapy.
Main Methods:
- Literature review of clinical evidence for neoadjuvant therapy in early breast cancer.
- Discussion of patient selection criteria.
- Considerations for monitoring treatment response.
- Surgical and radiotherapy planning post-neoadjuvant treatment.
Main Results:
- Neoadjuvant therapy offers significant benefits in managing early breast cancer.
- Evidence supports its use, but optimal patient selection remains key.
- Response monitoring and tailored surgical/radiotherapy approaches enhance outcomes.
Conclusions:
- Neoadjuvant therapy is an effective strategy for select early breast cancer patients.
- Multidisciplinary team input is vital for successful implementation.
- Standardizing patient selection and management protocols can improve treatment efficacy.
Related Concept Videos
02:49Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:53Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
01:26Drug Administration and Therapy Phases: Overview
1.5K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.5K